Economic_NewsDassault Systèmes in talks to buy drug trial software company for about $2bn Rutt ontrd1 hour ago01 mins Post Views: 7 Potential purchase of ArisGlobal from Swedish buyout group would boost French conglomerate’s push into life sciences 0 Reviews Post navigation Previous: Crypto.com valuation hits $20bn after investment from Citadel SecuritiesNext: Australian Dollar Price Forecast: Further gains remain on the cards